Neurocrine Biosciences Inc (NBIX)
138.97
-1.12
(-0.80%)
USD |
NASDAQ |
Apr 24, 16:00
139.00
+0.03
(+0.02%)
After-Hours: 20:00
Neurocrine Biosciences Cash and Short Term Investments (Quarterly): 1.032B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.032B |
| September 30, 2023 | 1.095B |
| June 30, 2023 | 976.70M |
| March 31, 2023 | 894.60M |
| December 31, 2022 | 989.30M |
| September 30, 2022 | 799.40M |
| June 30, 2022 | 648.30M |
| March 31, 2022 | 664.90M |
| December 31, 2021 | 711.30M |
| September 30, 2021 | 765.90M |
| June 30, 2021 | 884.90M |
| March 31, 2021 | 873.70M |
| December 31, 2020 | 801.00M |
| September 30, 2020 | 944.70M |
| June 30, 2020 | 948.30M |
| March 31, 2020 | 771.70M |
| December 31, 2019 | 670.50M |
| September 30, 2019 | 670.16M |
| June 30, 2019 | 619.98M |
| March 31, 2019 | 524.07M |
| December 31, 2018 | 650.91M |
| September 30, 2018 | 635.34M |
| June 30, 2018 | 508.74M |
| March 31, 2018 | 460.48M |
| December 31, 2017 | 515.93M |
| Date | Value |
|---|---|
| September 30, 2017 | 511.02M |
| June 30, 2017 | 525.02M |
| March 31, 2017 | 235.58M |
| December 31, 2016 | 307.35M |
| September 30, 2016 | 353.04M |
| June 30, 2016 | 387.40M |
| March 31, 2016 | 381.52M |
| December 31, 2015 | 379.19M |
| September 30, 2015 | 376.84M |
| June 30, 2015 | 384.72M |
| March 31, 2015 | 370.01M |
| December 31, 2014 | 193.81M |
| September 30, 2014 | 179.67M |
| June 30, 2014 | 194.66M |
| March 31, 2014 | 219.86M |
| December 31, 2013 | 145.74M |
| September 30, 2013 | 156.91M |
| June 30, 2013 | 153.70M |
| March 31, 2013 | 158.23M |
| December 31, 2012 | 173.01M |
| September 30, 2012 | 173.96M |
| June 30, 2012 | 177.54M |
| March 31, 2012 | 181.09M |
| December 31, 2011 | 129.10M |
| September 30, 2011 | 111.63M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
619.98M
Minimum
Jun 2019
1.095B
Maximum
Sep 2023
829.58M
Average
801.00M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Globus Medical Inc | 517.79M |
| Inspire Medical Systems Inc | 460.38M |
| AIM ImmunoTech Inc | 13.07M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |